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Convention defines pediatric adiposity by the body mass index 𝑧-score (BMIz) referenced to normative growth charts. Waist-
to-height ratio (WHtR) does not depend on sex-and-age references. In the HEALTHY Study enrollment sample, we compared
BMIz with WHtR for ability to identify adverse cardiometabolic risk. Among 5,482 sixth-grade students from 42 middle schools,
we estimated explanatory variations (𝑅2) and standardized beta coefficients of BMIz or WHtR for cardiometabolic risk factors:
insulin resistance (HOMA-IR), lipids, blood pressures, and glucose. For each risk outcome variable, we prepared adjusted regression
models for four subpopulations stratified by sex and high versus lower fatness. For HOMA-IR, 𝑅2 attributed to BMIz orWHtR was
19%–28% among high-fatness and 8%–13% among lower-fatness students.𝑅2 for lipid variables was 4%–9%among high-fatness and
2%–7% among lower-fatness students. In the lower-fatness subpopulations, the standardized coefficients for total cholesterol/HDL
cholesterol and triglycerides tended to be weaker for BMIz (0.13–0.20) than for WHtR (0.17–0.28). Among high-fatness students,
BMIz and WHtR correlated with blood pressures for Hispanics and whites, but not black boys (systolic) or girls (systolic and
diastolic). In 11-12 year olds, assessments byWHtR can provide cardiometabolic risk estimates similar to conventional BMIzwithout
requiring reference to a normative growth chart.
1. Introduction
The conventional definitions of pediatric adiposity depend
on a measured body mass index (BMI, kg/m2) interpreted
relative to a reference distribution (BMI normative growth
charts) for sex and age [1–3]. Because it has body weight
in its numerator, BMI reflects generalized (total-body)
enlargement with a simplified correction (as height2) for
skeletal size. Pediatric adiposity has been defined alternatively
by abdominal size, most commonly a waist circumference,
because increased truncal adipose tissue is correlated better
than generalized adiposity with cardiometabolic dysfunction
[4, 5]. Since waist circumference is a regionalmeasurement, it
reflects specifically only abdominal or central enlargement. It
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includes no correction for skeletal size.Thus, waist circumfer-
ence also requires interpretation relative to its own reference
distribution for sex and age. Comparisons of risk assessments
in youth have generally found little difference between BMI
and waist circumference in the ability of these indicators to
identify cardiometabolic risk [6, 7].
The waist-to-height ratio (WHtR) is an adiposity indi-
cator with waist circumference in the numerator and a
simplified correction (as height) for skeletal size. WHtR does
not depend on sex- or age-specific reference criteria [8–
10]. In a large sample of US sixth-graders, we examined the
performance of BMI 𝑧-score (BMIz, referenced to CDC 2000
growth charts for the United States [11]) and WHtR for the
purpose of cardiometabolic risk assessment.
2. Methods
2.1. Study Design and Participants. Participants came from
the baseline enrollment (sixth-grade students in 2006) of the
HEALTHY Study, a cluster-randomized, controlled, primary
prevention trial designed to improve indicators of adiposity
and glycemic dysregulation among US middle-school chil-
dren [12, 13]. Seven research centers recruited 42 middle
schools with at least 50% of students eligible to participate
in the federally subsidized National School Lunch Program
or belonging to an ancestral minority group at increased risk
of type 2 diabetes (Hispanic, non-Hispanic black, or Native
American). A detailed protocol and background details
about the HEALTHY Study are available for download at
http://www.healthystudy.org/.
We restricted a priori our analytic sample to students with
integer ages of 11 or 12 years who were able to participate
in physical education and did not have known diabetes.
From 5950 eligible enrollees, we excluded 13 students due to
missing or invalid data for the adiposity indicators (height,
weight, and waist circumference). Additional 239 students
were excluded for lack of outcome cardiometabolic risk
variables, and 216 were excluded for lack of information on
pubarche (an adjustment variable associatedwith adrenarche,
growth pattern, and insulin resistance) [14–16]. This left a
final sample of 5482 participants with complete data.
Participant ancestry (Hispanic, non-Hispanic black, non-
Hispanic white, other) and sex were self-reported. The study
was approved by each research center’s Institutional Review
Board, and informed consent from parents and assent from
students were obtained prior to data collection.
2.2. Adiposity Indicators, Blood Pressure, and Reporting of
Pubarche. From measured height and weight, we calculated
the sex- and age-specific BMIz based on the Centers for
Disease Control and Prevention 2000 growth charts [11, 17].
Waist circumference was measured to the nearest 0.1 cm on
bare skin just above the iliac crest following procedures of the
National Health and Nutrition Examination Survey [18], and
the WHtR was calculated.
Blood pressure was recorded three times using anOmron
automated blood pressure monitor (with appropriate-size
cuff) after the participant sat quietly for 5 minutes. The
mean of the second and third recordings was used in all
analyses. Pubarche was identified dichotomously from the
participants’ response to a standardized question on the
appearance of underarm and pubic hair [19].
2.3. Laboratory Methods. Fasting blood samples were pro-
cessed onsite and shipped to the HEALTHY central blood
laboratory (Northwest Lipid Research Laboratories, Uni-
versity of Washington) [12]. Insulin was measured by an
immunoenzymometric assay using a Tosoh 1800 autoana-
lyzer; the interassay and intra-assay precision analysis con-
sistently showed a coefficient of variation (CV) < 10%.
The assay had low cross-reactivity with human C-peptide
(0%) and proinsulin (2%). Glucose analyses were performed
on a Roche P module autoanalyzer using the hexokinase
method. The homeostasis model assessment of insulin resis-
tance (HOMA-IR) was calculated from glucose (mg/dL) and
insulin (𝜇U/mL) concentrations using the following formula
[20]:
HOMA-IR =
(glucose ∗ 0.05551) ∗ (insulin)
22.5
. (1)
Measurements of total plasma cholesterol, cholesterol in
the lipoprotein fractions, and triglycerides were performed
enzymatically on the Roche Modular-P autoanalyzer using
well-standardized methods. The interassay CVs were con-
sistently <1.5% for total cholesterol and triglycerides and
<2% for HDL cholesterol. We calculated the total-to-HDL
cholesterol ratio (Tc/HDLc), a variable that strongly predicts
cardiovascular disease in adults [21] and may be more
strongly associated than LDL-cholesterol or HDL-cholesterol
concentrations with pediatric adiposity [22, 23].
2.4. Statistical Analyses. In addition to stratification by sex,
we chose a priori to stratify our analyses by “high fatness” or
“lower fatness” because the ability of adiposity indicators to
identify adipose tissue mass, ectopic fat, and cardiometabolic
risk variables may be stronger among children in a higher
fatness category [23–26]. As defined for this report, the
high-fatness level included students who were above the
sex-specific median value for both BMIz and WHtR; any
student below the median for either adiposity indicator was
designated lower fatness. For each fatness level, we prepared
sex-specific, linear-regressionmodels adjusted for ancestry (4
categories) andpubarche (yes/no) to estimate the associations
of continuous adiposity indicators with the continuous car-
diometabolic risk factors (outcomes). Since blood pressure
varies with height in children [27, 28] our models for blood
pressure outcomes included an additional adjustment for
height which was entered as a continuous variable. For all
variables except BMIz, we calculated descriptive statistics
without using reference-based corrections for sex or age.
For indicators or outcomes that departed markedly from
a normal distribution (WHtR, HOMA-IR, Tc/HDLc, HDL
cholesterol, triglycerides, and (only for lower-fatness stu-
dents) diastolic blood pressure), we transformed the variable
by log
𝑒
or inverse square root to approach normality prior to
their use in regression models [29].
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Table 1: Description of cross-sectional sample at grade 6 (𝑁 = 5,482).
Boys (𝑛 = 2,585) Girls (𝑛 = 2,897)
Median Mean SD Median Mean SD
Continuous variables, units
Age, years 11.8 11.8 0.5 11.7 11.7 0.4
Weight, kg 47.8 51.0 15.6 48.2 51.4 15.1
Height, cm 149.8 150.2 8.1 151.6 151.4 7.2
Body mass index, kg/m2 21.1 22.3 5.4 20.9 22.2 5.4
BMI 𝑧-score 1.118 0.958 1.090 0.917 0.827 1.075
Waist circumference, cm 72.5 75.8 15.3 72.9 75.5 14.0
WHtR 0.484 0.503 0.091 0.480 0.498 0.084
HOMA-IR 2.1 2.9 2.9 2.6 3.3 2.7
Total cholesterol/HDL cholesterol 3.0 3.1 0.9 2.9 3.1 0.8
HDL cholesterol, mmol/L 1.34 1.38 0.33 1.32 1.35 0.31
Triglycerides, mmol/L 0.84 0.99 0.59 0.87 1.01 0.57
Systolic BP, mmHg 107.5 108.1 10.2 106.5 106.8 9.7
Diastolic BP, mmHg 63.0 63.5 8.9 63.5 63.9 8.6
Glucose, mg/dL 94.0 94.4 6.6 92.0 92.6 6.6
Categorical variables, % — —
Fatness levela (high/lower) 45.9 / 54.1 44.6 / 55.4
Ancestryb (H/B/W/other) 52.2 / 18.4 / 21.2 / 8.2 53.9 / 19.7 / 18.0 / 8.4
Pubarche (no/yes) 73.5 / 26.5 57.2 / 42.8
aHigh-fatness students identified by being above the sex-specific median value for both BMI 𝑧-score and WHtR; the remaining students were designated as
lower-fatness.
bH: Hispanic; B: non-Hispanic black; W: non-Hispanic white.
Our adjusted models estimated standardized beta coef-
ficients (change in the outcome variable (in standard devi-
ations) associated with change of one standard deviation in
the adiposity indicator) for each cardiometabolic risk factor.
PROCMIXED (SAS version 9.2; SAS Institute Inc., Cary, NC)
was used to account for variability both within and between
the school clusters. In these mixed models, the proportion
of variation explained (𝑅2) by each adiposity indicator was
calculated as the full model 𝑅2 minus 𝑅2 for a model
omitting the adiposity indicator. To compare linear slopes
among ancestral groups, mixed-regression models estimated
nonstandardized, beta-regression coefficients; interactions
were tested between each adiposity indicator and the three
ancestries represented prominently in our sample (Hispanic,
black, and white). We report as noteworthy those ancestral
contrasts where 𝑃 < 0.01.
3. Results
Characteristics of the analytic sample are presented by sex in
Table 1. As expected for sixth-grade students [30], girls had
greater height, insulin resistance, and triglycerides than boys.
Following further stratification by fatness level, the distribu-
tions of adiposity indicators and ancestry are summarized in
Table 2. Compared to the high-fatness groups in our sample,
the lower-fatness groups had BMI and WHtR distributions
that resembled more closely the general population of US
youth in the same age range [31, 32].
Within the high-fatness subpopulations of either sex
(Table 3), adiposity indicators explained 19%–28% of the
variation inHOMA-IR, 4%–9%of the variation in circulating
lipids (Tc/HDLc, HDL cholesterol, triglycerides), and 5%–
9% of the variation in diastolic blood pressure. Adiposity
indicators explained <3% of the variations in systolic blood
pressure and fasting glucose. For each outcome variable in
these high-fatness subpopulations, the effect sizes (standard-
ized beta coefficients) associated with BMIz were similar to
those associated with WHtR.
Within the lower-fatness subpopulations of either sex
(Table 4), adiposity indicators explained 8%–13% of the vari-
ation in HOMA-IR and 2%–7% of the variation in circulating
lipids. For Tc/HDLc and triglycerides, the standardized beta
coefficients tended to be weaker for BMIz (0.13–0.20) than
for WHtR (0.17–0.28). Adiposity indicators in these lower-
fatness subpopulations explained <1% of the variations in
systolic blood pressure, diastolic blood pressure, and fasting
glucose.
A comparison between the two levels of fatness (Table 3
versus Table 4) demonstrates that for either adiposity indi-
cator the associations with HOMA-IR were stronger among
the high-fatness students (beta coefficients 0.43–0.52) than
among the lower-fatness students (0.30–0.37). Similarly, both
adiposity indicators were associated with diastolic blood
pressure more strongly among high-fatness students (0.23–
0.32; 𝑃 < 0.001 for each of 4 beta coefficients) than among
lower-fatness students (0.03–0.05; 𝑃 > 0.05 for each of
four beta coefficients). For identification of lipid outcomes,
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Table 2: Distributions of adiposity indicators and ancestral groups.The analytic sample is divided into fourmutually exclusive subpopulations
by sex and fatness level.
Boys Girls
High fatnessa
𝑛 1,187 1,291
Body mass index, median (p25, p75) 25.9 (23.6, 29.2) 25.8 (23.4, 29.3)
BMI𝑧, median (p25, p75) 1.91 (1.60, 2.20) 1.78 (1.41, 2.14)
WHtR, median (p25, p75) 0.574 (0.533, 0.625) 0.562 (0.524, 0.614)
Ancestryb (H/B/W/other), % 61.0 / 13.1 / 18.8 / 7.2 58.6 / 18.4 / 15.4 / 7.5
Lower fatness
𝑛 1,398 1,606
Body mass index, median (p25, p75) 18.3 (16.9, 19.8) 18.3 (16.8, 19.9)
BMI𝑧, median (p25, p75) 0.258 (−0.361, 0.754) 0.170 (−0.443, 0.657)
WHtR, median (p25, p75) 0.432 (0.408, 0.457) 0.436 (0.411, 0.460)
Ancestryb (H/B/W/other), % 44.8 / 23.0 / 23.2 / 9.0 50.0 / 20.8 / 20.1 / 9.1
aHigh-fatness students identified by being above the sex-specific median value for both BMI 𝑧-score and WHtR; the remaining students were designated as
lower-fatness.
bH: Hispanic; B: non-Hispanic black; W: non-Hispanic white.
p25 and p75 represent the 25th and 75th percentile values, respectively.
Table 3: Associations comparing standardized BMI 𝑧-score with standardized WHtR for estimating risk variable outcomes among high-
fatness students (𝑁 = 2,478).
Risk outcome
Boys (𝑛 = 1,187) Girls (𝑛 = 1,291)
BMI 𝑧-score WHtR−0.5 BMI 𝑧-score WHtR−0.5
Standardized beta
𝑅
2 Standardized beta
𝑅
2 Standardized beta
𝑅
2 Standardized beta
𝑅
2
(95% CI) (95% CI) (95% CI) (95% CI)
Log HOMA-IR 0.52 0.277 0.48 0.234 0.47 0.213 0.43 0.195
(0.48–0.57) (0.43–0.53) (0.42–0.52) (0.38–0.48)
Log Tchol/HDLchol 0.29 0.083 0.29 0.084 0.23 0.057 0.27 0.075
(0.23–0.34) (0.24–0.35) (0.18–0.29) (0.22–0.33)
Log HDL cholesterol −0.30 0.092 −0.28 0.077 −0.27 0.075 −0.28 0.079
(−0.35–−0.24) (−0.33–−0.22) (−0.32–−0.21) (−0.34–−0.23)
Log triglycerides 0.24 0.061 0.24 0.058 0.19 0.037 0.22 0.052
(0.19–0.29) (0.18–0.29) (0.14–0.24) (0.17–0.27)
Systolic BPa, mmHg 0.17 0.028 0.10 0.011 0.15 0.021 0.08
∗
0.006
(0.11–0.22) (0.05–0.16) (0.09–0.20) (0.03–0.13)
Diastolic BPa, mmHg 0.32 0.094 0.29 0.088 0.28 0.072 0.23 0.054
(0.26–0.37) (0.23–0.34) (0.22–0.33) (0.18–0.28)
Glucose, mg/dL 0.04
†
0.001 0.02
†
0.000 0.08
∗
0.005 0.06
∗
0.003
(−0.02–0.10) (−0.04–0.07) (0.03–0.13) (0.01–0.12)
aModels for blood pressures include an additional adjustment for height.
𝑅
2 is the proportion of variation explained by the adiposity indicator.
All beta coefficients are 𝑃 < 0.001 with exception of ∗(𝑃 < 0.05) and †(𝑃 > 0.05), not significant.
Note that WHtR−0.5 is equivalent to 1/√WHtR or 1/WHtR0.5.
however, we found steeper beta coefficients only among
high-fatness boys (compared to lower-fatness boys) whose
adiposity was assessed by BMIz. For both sexes assessed by
WHtR, the beta coefficients were similar across the fatness
levels.
The associations between adiposity indicators and risk
variables were not notably different between the Hispanics,
non-Hispanic blacks, and non-Hispanic whites except when
related to blood pressure outcomes. Although adiposity
explained 5%–7% of variation in diastolic blood pressure
in the complete sample of high-fatness girls (Table 3), this
relationship was extremely weak for high-fatness girls who
were black, as indicated by slope point estimates close to zero
(Figure 1). However, for high-fatness girls who were Hispanic
or white, BMIz and WHtR had significant associations
(𝑃 < 0.05) with diastolic pressure. Among high-fatness
boys, we found no ancestral contrasts related to diastolic
pressure.
Journal of Obesity 5
Table 4: Associations comparing standardized BMI 𝑧-score with standardized WHtR for estimating risk variable outcomes among lower-
fatness students (𝑁 = 3,004).
Risk outcome
Boys (𝑛 = 1,398) Girls (𝑛 = 1,606)
BMI 𝑧-score log WHtR BMI 𝑧-score Log WHtR
Standardized beta
𝑅
2 Standardized beta
𝑅
2 Standardized beta
𝑅
2 Standardized beta
𝑅
2
(95% CI) (95% CI) (95% CI) (95% CI)
Log HOMA-IR 0.34 0.117 0.30 0.083 0.37 0.133 0.31 0.098
(0.29–0.39) (0.25–0.35) (0.32–0.42) (0.27–0.36)
Log Tchol/HDLchol 0.18 0.031 0.26 0.063 0.20 0.041 0.28 0.074
(0.13–0.22) (0.21–0.32) (0.15–0.25) (0.23–0.33)
Log HDL cholesterol −0.19 0.038 −0.20 0.037 −0.22 0.049 −0.24 0.053
(−0.24–−0.14) (−0.26–−0.15) (−0.27–−0.17) (−0.29–−0.19)
Log triglycerides 0.14 0.018 0.22 0.042 0.13 0.015 0.17 0.031
(0.09–0.19) (0.16–0.27) (0.08–0.18) (0.12–0.22)
Systolic BPa, mmHg 0.03
†
0.000 −0.01
†
<0.001 0.04
†
0.001 0.00
†
<0.001
(−0.02–0.08) (−0.06–0.04) (−0.01–0.09) (−0.05–0.05)
Log diastolic BPa 0.03
†
0.000 0.05
†
0.002 0.04
†
0.001 0.05
†
0.002
(−0.03–0.08) (−0.00–0.11) (−0.01–0.09) (−0.00–0.10)
Glucose, mg/dL 0.06
∗
0.004 0.05
†
0.002 0.07
∗
0.004 0.04
†
0.002
(0.01–0.11) (−0.01–0.10) (0.02–0.12) (−0.02–0.09)
aModels for blood pressures include an additional adjustment for height.
𝑅
2 is the proportion of variation explained by the adiposity indicator.
All beta coefficients are 𝑃 < 0.001 with exception of ∗(𝑃 < 0.05) and †(𝑃 > 0.05), not significant.
Systolic blood pressure was not significantly associated
with BMIz or WHtR for high-fatness blacks of either sex,
but the association was present for high-fatness students
who were Hispanic or white. An ancestral contrast (blacks
compared to whites) related to systolic blood pressure
was significant, however, only among the high-fatness girls
assessed by BMIz (Figure 1; 𝑃 < 0.01).
4. Discussion
In this large sample of middle-school students at increased
risk of obesity and type 2 diabetes, we found that adiposity
indicators BMIz (with reference to CDC 2000 growth charts)
andWHtR (without reference to sex and age) had similar util-
ity for identifying adverse levels of cardiometabolic variables.
Our findings are generally consistent with previous published
reports, most of which were based on populations that had a
wider age range or included less ancestral diversity. Earlier
cross-sectional studies that compared continuous WHtR
against BMI either without a normative growth reference
[33–35] or with reference-based BMI 𝑧-scores/percentile
ranks [23, 36] generally found that WHtR provided stronger
associations with lipid outcomes, but BMI was superior for
blood pressure outcomes. A recent report on sixth-grade
students from Switzerland found that BMIz (referenced to
CDC 2000 growth charts) and WHtR provided associations
with blood pressures that were weak but nearly identical
[37]. In studies of youth from the southern US, BMIz
provided a slightly stronger association than WHtR with
HOMA-IR [38] and fasting insulin [23], a relationship that
was complicated by nonlinearity. Nationally representative,
cross-sectional data from the US demonstrated thatWHtR at
ages 4–17 years was more strongly associated than BMIz with
resting heart rate [36]. A longitudinal analysis from the same
survey of adolescent and young-adult participants found that
categorical WHtR predicted all-cause mortality before age 55
better than categorical BMIz (baseline ages 12–18 years) or
BMI (ages 19–39) [39]. From the United Kingdom, a large
study recently reported thatWHtR andBMIz obtained at ages
7–9 years had similar associations with cross-sectional and
prospective cardiometabolic risk factors in adolescence [40].
Given an approximately equal utility of BMIz and WHtR
for pediatric health assessments, we should consider how
these adiposity indicators might perform in different settings
or in the future. BMIz values reported in the research litera-
ture depend on standardized protocols for measuring height
and weight using calibrated, high-quality scales. In nonre-
search settings, however, staff training and time pressures
might not be so favorable to careful measurements [41]. The
dependence of BMIz on normative growth references can be
problematic because BMI-for-age reference values can yield
discrepant inferences between populations, time periods [3],
and ethnicities within a single country [42].The International
Obesity Task Force prepared a “worldwide” BMI growth
reference based on large datasets from six countries [43],
but subsequent reviews found that this international growth
reference provided no advantage over national BMI growth
references for the definition of excessive fat mass in youth [6]
or prediction of subsequent cardiovascular risk in adulthood
[44]. The World Health Organization (WHO) more recently
developed a BMI-based growth reference [45], the utilization
of which has been described as a cumbersome task in need
of simplification [46]. Surveys from various clinical settings
6 Journal of Obesity
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Figure 1: Within the high-fatness subpopulations, the point estimates (with 95% confidence intervals) represent here the slopes of the
associations between blood pressure and either BMIz or WHtR for 3 predominant ancestral groups (Hispanic, black, and white). Black
participants exhibited no linear associations between systolic blood pressure and increasing adiposity (a). Diastolic blood pressure was related
to increasing adiposity for black boys, but not black girls (b).
have found generally that the use of BMI-for-age reference
values is suboptimal [47–50].
Advocates of the WHtR must address problems associ-
ated with the available protocols for measuring waist size.
While tapemeasures are inexpensive and generally need little
calibration, protocols for circumference measurement are
still unfamiliar to many pediatric practitioners or clinic assis-
tants. Our study carefully measured the waist circumference
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just above the iliac crest, an anatomic location endorsed
by prominent researchers in the United States [18, 51] and
Canada [52]. The WHO, however, recommends measuring
waist circumference at the approximate midpoint between
the lower margin of the last palpable rib and the top of the
iliac crest [53]. Waist circumferences have been taken also
at the level of the umbilicus, the “minimal waist,” and other
sites [54, 55]. In an anthropometric study of diabetic youth,
the iliac-crest protocol and WHO protocol demonstrated
comparable reproducibility, but these alternative protocols
yielded notable differences in the absolute value of a waist
circumference obtained from the same participants [56].
A study of overweight youth found that the WHO waist-
circumference protocol had a stronger association than the
iliac-crest protocol with cardiometabolic risk [57], and stud-
ies of adult waist circumference have likewise suggested an
advantage for the WHO protocol [58–60]. It follows that
the WHtR values calculated from the iliac-crest and WHO
protocols should not be casually substituted for each other.
It is possible that if our HEALTHY Study had adopted
the WHO instead of the iliac-crest protocol for its baseline
anthropometry, the re-calculatedWHtR indicatormight have
demonstrated stronger associations with cardiometabolic
risk variables than those we report in this paper. However,
suchWHOmeasurements are not available in theHEALTHY
Study.
Standardization of a single waist-circumference protocol
would probably advance the widespread adoption of the
WHtR as a low-cost adiposity indicator [55, 61]. As an alter-
native to the circumference, some pediatric investigators have
described waist size in selected participants by measuring
the external diameter sagittally (back-to-front) in the supine
position [62–64]. Their reports suggest that standardization
of a “sagittal abdominal diameter” protocol might further
enhance studies that are cross-sectional or involve short-
term follow-up of central adiposity, but this anthropometric
method needs to be tested in larger datasets that represent
general youth populations.
The physiological importance of tissues accumulated
in the waist may help to explain why WHtR was more
closely associated than BMIz with variations in the levels of
circulating lipid markers among our lower-fatness partici-
pants (Table 4). An increase in waist size primarily marks
expanding amounts of adipose tissue, including notably the
visceral depot which is most strongly associated with an
adverse metabolic phenotype [5, 65]. Variation in the waist
circumference can explain more than 64% of the variance in
the area [66] or volume [67] of visceral adipose tissue. An
increase in BMI, by contrast, may substantially mark also the
variations in gain ofmuscular weight or subcutaneous fat pat-
terning that precede adulthood [1]. Along with the changes in
fat mass, these variations in lean mass or superficial adipose
tissue contribute to the BMI calculation while contributing
relatively little to metabolic risk.
Although high-fatness Hispanic and white girls in our
study demonstrated the expected associations between adi-
posity and blood pressure, we found among the high-fatness
black girls (but not black boys) that neither BMIz nor
WHtR had a significant association with blood pressure
outcomes (Figure 1). In comparison to young Hispanics and
whites, young blacks tend to have abdominal adipose tissue
relatively less in the visceral depot andmore in the abdominal
subcutaneous regions [68]. Another study has also reported
that black girls’ waist circumference around the same age
was unrelated to their diastolic blood pressure [69]. Since
both the BMIz and WHtR indicators demonstrated similar
patterns of nonassociation with black girls’ blood pressure, it
may be that this absence of a correlation with blood pressure
is due to factors operating primarily outside the abdominal
region. Perhaps black girls benefit from an increased capacity
to expand their lower-body (gluteofemoral), subcutaneous,
adipose-tissue stores in a manner that would increase their
total body weight yet protect them from cardiometabolic risk
[70–73]. If this protective characteristic of black girls extends
into their later years, it could help explain why adult black
women in the US experience no increased cardiometabolic
risk [74] or mortality [75] until their BMI reaches approxi-
mately 33 kg/m2.
5. Conclusions
If a well-standardized waist measurement comes into
widespread use for clinical assessments of pediatric
adiposity, patients and their families may improve their
intuitive understanding of how excess adiposity contributes
to adverse health risk. Pediatric health care providers, too,
may find it more useful to recognize risk associated with a
waist increment (corrected for height) than with a weight
increment (corrected for height squared). Adoption of
the WHtR could optimize both patient education and the
tracking of risk [76]. Compared to BMI, the WHtR allows
a simpler calculation without the necessity of squaring the
child’s height. Of interest to those concerned with child
adiposity and cardiometabolic risk observed in different
cultures or distinct time periods, the WHtR will facilitate
comparisons based directly on anthropometric observations
without using normative reference tables that may not be
suitable to all populations [77–79].
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